KIOM-79 Reduces Inflammation in Diabetic Rats
Author Information
Author(s): Eunjin Sohn, Junghyun Kim, Il Ha Jeong, Chan Sik Kim, Young Sook Kim, Jin Sook Kim
Primary Institution: Korea Institute of Oriental Medicine
Hypothesis
Does KIOM-79 reduce advanced glycation end product accumulation and inflammatory factors in the aorta of Zucker diabetic fatty rats?
Conclusion
KIOM-79 may help prevent or slow down inflammation in diabetic vascular disease by reducing AGE accumulation and inflammatory factor expression.
Supporting Evidence
- KIOM-79 significantly reduced AGE expression by 37.8% compared to untreated ZDF rats.
- RAGE expression was significantly decreased in ZDF rats treated with KIOM-79.
- Inflammatory factors MCP-1, VEGF, and VCAM-1 were significantly reduced in the aorta of ZDF rats treated with KIOM-79.
Takeaway
KIOM-79 is a herbal treatment that helps diabetic rats by reducing harmful substances in their blood vessels and lowering inflammation.
Methodology
Male Zucker diabetic fatty rats were treated with KIOM-79 for 13 weeks, and various inflammatory factors and AGE accumulation were measured in their aortas.
Potential Biases
Potential bias in the selection of treatment groups and measurement methods.
Limitations
The study was conducted on a specific rat model, which may not fully represent human diabetes.
Participant Demographics
Male Zucker diabetic fatty rats, aged seven weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website